Rare diseases
Investigational molecules
Locations
Back to Germany2 clinical trials in Sigmaringen, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on triple-negative breast cancer treatment, combining chemotherapy with novel immunotherapy approaches. The research aims to evaluate the effectiveness of combining traditional treatments with new therapeutic agents.
Studies are designed to improve survival rates and treatment outcomes for patients with early-stage breast cancer.
Ongoing research in B-cell malignancies explores long-term treatment options using targeted therapy approaches. These trials evaluate innovative treatments for blood cancers affecting the lymphatic system.
Research focuses on developing sustainable treatment regimens for patients with lymph node-related blood cancers.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
